 MEDFORD, Mass. AUSTIN, Texas--BUSINESS WIRE--- TFFP COVID--GreenLight Biosciences and TFF Pharmaceuticals enter into feasibility arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine. 